London, United Kingdom

Charles Massie

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cancer Research Technology Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Massie. Retrieved from https://idiyas.com/inventor/charles-massie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Charles Massie and a Patent for Detecting Tumor-Related DNA

Introduction

Charles Massie is an inventor associated with Cancer Research Technology Limited in London, United Kingdom. His patent work concerns detecting cell-free DNA, including circulating tumor DNA, in samples obtained from patients.

Latest Patents

The provided information lists one patent for Charles Massie: “Variant detection.” The invention describes a computer-implemented method that examines sequence data from a patient’s DNA-containing sample. It focuses on at least two mutation-containing loci associated with that patient’s tumor, calculates the mutant allele fraction across some or all of those loci, and uses the result to classify whether the sample contains the target cell-free DNA. The method may also group sequence reads into read families, and the patent describes related methods and systems. Massie is credited with 1 patent in the information provided.

Career Highlights

Massie’s listed patent connects his work with cancer research and molecular analysis. The invention’s patient-specific approach uses multiple tumor-associated loci to support the detection of circulating tumor DNA.

Collaborations

The provided information names Christopher G. Smith and Florent Mouliere as Massie’s coworkers. It does not specify their roles in the patent or describe particular collaborative projects.

Conclusion

Charles Massie’s listed invention addresses the detection of tumor-related cell-free DNA through analysis of patient-specific mutations, reflecting the application of computational methods to cancer research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…